Background The optimal revascularization strategy of coronary artery bypass grafting
(CABG) versus percutaneous coronary intervention with drug-eluting stent (PCI-DES) in …

Background: Chronic kidney disease (CKD) is a strong predictor of mortality after
percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), but the …

Background: Randomized trials of percutaneous coronary intervention (PCI) versus
coronary artery bypass graft (CABG) routinely exclude patients with chronic kidney disease …

Results Median follow-up duration was 41.4 (interquartile range 12.1-75.5) months. The
primary outcome occurred in 307 (26.4%) patients in the PCI group compared with 304 …

Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients
with chronic kidney disease (CKD), but no study has yet compared the short-and long-term …

Background—There is a paucity of data on the comparative effectiveness of percutaneous
coronary intervention using contemporary drug-eluting stent (DES) compared with coronary …

Objectives To compare the long-term outcomes of coronary artery bypass grafting (CABG)
vs. percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) for coronary …

Το perform a systematic review and meta-analysis of the available literature comparing
safety and efficacy outcomes between percutaneous coronary intervention (PCI) with drug …

Background: Early revascularization can lead to better prognosis in multivessel coronary
artery disease (CAD) patients with chronic kidney disease (CKD). However, whether …

Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease
and death, yet little data exist regarding the comparative efficacy of coronary …